About

Oviya MedSafe is a global Pharmacovigilance consulting & Drug Safety services company incorporated in India in 2012 and in the United Kingdom in 2014, offering advisory and outsourced support to the pharmaceutical industry. Oviya MedSafe is backed by 100 years of collective intelligence of its founding groups and works with renowned pharmaceutical companies and marketing authorization holders in various parts of the world.

Oviya MedSafe provides end-to-end global drug safety support (combined with regulatory-compliant drug safety database access, as required) to pharmaceutical companies with mature pharmacovigilance systems. More importantly, Oviya MedSafe comprehensively consults to generic pharmaceutical companies across the globe to help them constantly evolve their pharmacovigilance departments to be in line with the regulations pertinent to their market presence.


Vision: To become a leader in pharmacovigilance consulting services by strategically partnering with global pharmaceutical companies.

Mission: To inculcate a pharmacovigilant culture and proactively support the growth of drug safety practices across the globe. We will achieve this by integrating our expertise in pharmacovigilance with our medical experience, ensuring compliance to the dynamic regulatory frameworks and deploying the most appropriate technology.

Values:

*Passion for Pharmacovigilance
*Continuous learning to empower clients
*Perpetual capability building
*Deep-rooted business integrity


About Our Founder:

Dr J Vijay Venkatraman founded Oviya MedSafe in 2012. He is a Diabetologist, Drug Safety Physician and Entrepreneur, with about 25 years of experience. He holds a MBA degree in Services Management. He is the first Indian to have been conferred the Fellowship of the Pharmaceutical Information & Pharmacovigilance Association (PIPA), United Kingdom.

Dr Vijay has held the honorary position ‘Regional Editor, India’ of Global Forum, the official magazine of the Drug Information Association (DIA) since April 2017. He served as the Chairman of the Indian Medical Association (IMA) Headquarters’ Standing Committee for Pharmacovigilance for the year 2021. He was the Chair of the Pharmacovigilance Council of the Indian Society for Clinical Research (ISCR) since the inception of the council in April 2015 until 2019.

Dr Vijay has been an invited faculty in conferences around the world. He has numerous publications to his credit and has often been featured in the media. He is a member of several professional associations and is actively involved in promoting pharmacovigilance awareness among all stakeholders of the discipline.

Dr Vijay is a recipient of many awards including the ‘Leadership Excellence Award’ and the ‘State Appreciation Award for Co-ordinating Academic Activities’ by the Indian Medical Association.


Why Oviya MedSafe?

Oviya MedSafe has been positioned to leverage its expertise in Pharmacovigilance, an industry which is evolving with new and updated regulations day by day. We are capable of providing modular solutions in terms of Drug Safety services, along with regulatory-compliant drug safety database access, as required.

We aspire to bridge the crucial gap in the industry where end-to-end pharmacovigilance services are always in demand. Oviya MedSafe is fueled by a passion for pharmacovigilance. We not only assure timely delivery and the highest quality of our services but also ensure that proper business continuity and disaster recovery plans are implemented in order to resume the key business activities within a short while.

Your data confidentiality is our topmost priority. Therefore, our business model ensures that your data with us is as safe as it is when it is with you. Our global delivery centre is equipped with the state-of-the-art infrastructure and qualified drug safety teams to handle your data with utmost care.

We bring a lot of energy and dynamism to the table, along with years of pharmacovigilance, medical and management experience. Contact us with your requirements and be assured of unique and unparalleled services.